New research reveals a surprising PMOS link to cardiovascular threats, raising concerns about awareness, diagnosis delays and women’s long-term health.

New research suggests women with polyendocrine metabolic ovarian syndrome (PMOS) face a four times higher heart disease risk in Women compared with those without the condition. A US study analyzing more than 2.4 million health records from 2000 to 2022 found that PMOS patients aged 18 to 50 had a stronger link to cardiovascular disease, even after accounting for diabetes, high blood pressure and other risk factors.

Study highlights rising cardiovascular concerns

Researchers published the findings in The Lancet Obstetrics, Gynaecology, & Women’s Health after reviewing insurance data involving 413,450 women with PMOS. The condition, previously known as polycystic ovarian syndrome (PCOS), affects hormones, periods, fertility, hair growth and mood.

Key findings from the research:

  • PMOS patients showed fourfold higher heart disease risk

  • Study analyzed over two million comparison health records

  • Risk remained after adjusting major cardiovascular health factors

  • Researchers urged earlier prevention and patient awareness

  • Experts called for improved long-term PMOS management

Why early screening remains important

International PMOS guidelines recommend cardiovascular screening at diagnosis, along with lifestyle guidance to reduce future complications. However, researchers noted that many patients experience delayed diagnosis and limited counseling about long-term health risks.

The study team highlighted the need for stronger physician education and better awareness among women. Early interventions may help address cardiovascular disease risk factors before serious complications develop.

PMOS is increasingly recognized as a broader metabolic health concern rather than only a reproductive disorder. Experts believe improved diagnosis methods, regular medical reviews and personalized care plans could help reduce the long-term impact of the condition on women’s health.

New focus on treatment and monitoring

Researchers called for additional studies examining women through menopause and exploring whether treatments such as GLP-1 medications or hormonal contraception influence the connection between PMOS and heart disease.

The National Institute for Health and Care Excellence (Nice) recently recommended annual health reviews for women with PMOS to monitor symptoms and manage long-term risks. Experts say consistent care could improve outcomes for millions affected by the condition.

The findings also reinforce the importance of understanding links between hormonal disorders, metabolic changes and cardiovascular health. As awareness grows, healthcare providers may focus more on preventive strategies, early intervention and continuous monitoring for women living with PMOS.

Accordingly, Business Fortune believes that increasing PMOS awareness and screening can promote cardiovascular prevention and healthier futures.

FAQs

What is PMOS and how does it affect women?

PMOS is a complex hormonal and metabolic condition that can affect menstrual health, fertility, hair growth, mood and overall wellbeing.

How does PMOS increase heart disease risk in women?

Research shows women with PMOS have a significantly higher risk of developing heart disease due to associated metabolic and cardiovascular risk factors.

Why was PCOS renamed PMOS?

Experts recommended the name change because the previous term created confusion by focusing mainly on ovarian cysts rather than the wider hormonal and metabolic effects.

What health checks are recommended for women with PMOS?

Healthcare guidelines suggest regular cardiovascular risk assessments, symptom monitoring and lifestyle support to manage potential long-term complications.

Can early PMOS management reduce heart disease risks?

Early diagnosis, preventive care, regular medical reviews and personalized treatment plans may help improve long-term health outcomes for women with PMOS.